ENDRA LIFE SCIENCES INC. Stock-Based Compensation
ENDRA LIFE SCIENCES INC. (NDRA) reported Stock-Based Compensation of $1.12 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- ENDRA LIFE SCIENCES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $541.90K, a 1270.87% increase year-over-year.
- ENDRA LIFE SCIENCES INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $574.45K, a 591.73% increase year-over-year.
- ENDRA LIFE SCIENCES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $12.88K, a 87.70% decline year-over-year.
- ENDRA LIFE SCIENCES INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $144.72K.
- ENDRA LIFE SCIENCES INC. share-based payment arrangement, noncash expense for fiscal 2025 was $329.41K, a 42.40% decline from fiscal 2024.
- ENDRA LIFE SCIENCES INC. share-based payment arrangement, noncash expense for fiscal 2024 was $571.92K, a 42.60% decline from fiscal 2023.
- ENDRA LIFE SCIENCES INC. share-based payment arrangement, noncash expense for fiscal 2023 was $996.43K, a 16.95% decline from fiscal 2022.
- ENDRA LIFE SCIENCES INC. share-based payment arrangement, noncash expense for fiscal 2022 was $1.20M, a 16.94% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $541.90K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $1.12M 10-Q · filed 2026-08-14 | $1.13M derived: sum of 3 quarters · filed 2026-08-14 | $1.27M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $574.45K 10-Q · filed 2026-05-15 | $587.33K derived: sum of 2 quarters · filed 2026-05-15 | $732.05K derived: sum of 3 quarters · filed 2026-05-15 | $771.58K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | $12.88K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $157.60K derived: sum of 2 quarters · filed 2026-03-31 | $197.13K derived: sum of 3 quarters · filed 2026-03-31 | $329.41K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $144.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $184.25K derived: sum of 2 quarters · filed 2025-11-14 | $316.53K 10-Q · filed 2025-11-14 | $371.98K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-06-30 | $39.53K 10-Q · filed 2025-08-14 | $171.81K 10-Q · filed 2026-08-14 | $227.26K derived: sum of 3 quarters · filed 2026-05-15 | $190.41K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-03-31 | $83.05K 10-Q · filed 2026-05-15 | $187.73K derived: sum of 2 quarters · filed 2026-05-15 | $150.88K derived: sum of 3 quarters · filed 2026-05-15 | $337.47K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2024-12-31 | $104.68K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $67.84K derived: sum of 2 quarters · filed 2026-03-31 | $254.43K derived: sum of 3 quarters · filed 2026-03-31 | $571.92K 10-K · filed 2026-03-31 | |
| 2024-09-30 | -$36.85K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $149.74K derived: sum of 2 quarters · filed 2025-11-14 | $467.24K 10-Q · filed 2025-11-14 | $717.80K derived: sum of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | $186.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $504.09K 10-Q · filed 2025-08-14 | $754.64K derived: sum of 3 quarters · filed 2025-08-14 | $1.01M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $317.50K 10-Q · filed 2025-05-15 | $568.05K derived: sum of 2 quarters · filed 2025-05-15 | $820.79K derived: sum of 3 quarters · filed 2025-05-15 | $1.08M derived: sum of 4 quarters · filed 2025-05-15 | |
| 2023-12-31 | $250.56K derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-04-07 | $503.30K derived: sum of 2 quarters · filed 2025-04-07 | $759.15K derived: sum of 3 quarters · filed 2025-04-07 | $996.43K 10-K/A · filed 2025-04-07 | |
| 2023-09-30 | $252.74K derived: 10-Q/A 9 month − 10-Q 6 month · filed 2024-11-21 | $508.59K derived: sum of 2 quarters · filed 2024-11-21 | $745.87K 10-Q/A · filed 2024-11-21 | $1.04M derived: sum of 4 quarters · filed 2024-11-21 | |
| 2023-06-30 | $255.85K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-14 | $493.13K 10-Q · filed 2024-08-14 | $783.90K derived: sum of 3 quarters · filed 2024-08-14 | $1.69M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $237.28K 10-Q · filed 2024-05-14 | $528.05K derived: sum of 2 quarters · filed 2024-05-14 | $1.44M derived: sum of 3 quarters · filed 2024-05-14 | $1.15M derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $290.77K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $1.20M derived: sum of 2 quarters · filed 2024-03-28 | $911.30K derived: sum of 3 quarters · filed 2024-03-28 | $1.20M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $909.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $620.53K derived: sum of 2 quarters · filed 2023-11-14 | $909.07K 10-Q · filed 2023-11-14 | $1.32M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | -$288.54K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $0.00 10-Q · filed 2023-08-14 | $599.89K 10-Q · filed 2022-08-15 | $411.74K derived: sum of 3 quarters · filed 2023-08-14 | $739.54K derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $288.54K 10-Q · filed 2023-05-15 | $700.27K derived: sum of 2 quarters · filed 2023-05-15 | $1.03M derived: sum of 3 quarters · filed 2023-05-15 | $1.41M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | $411.74K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $739.54K derived: sum of 2 quarters · filed 2023-03-16 | $1.12M derived: sum of 3 quarters · filed 2023-03-16 | $1.44M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $327.80K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $710.89K derived: sum of 2 quarters · filed 2022-11-14 | $1.03M 10-Q · filed 2022-11-14 | $1.58M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $383.09K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $705.04K 10-Q · filed 2022-08-15 | $1.25M derived: sum of 3 quarters · filed 2022-08-15 | ||
| 2021-03-31 | $321.95K 10-Q · filed 2022-05-12 | $865.07K derived: sum of 2 quarters · filed 2022-05-12 | |||
| 2020-12-31 | $543.12K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $2.10M 10-K · filed 2022-03-30 | |||
| 2020-09-30 | $1.56M 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |